Clinical Trial Update: Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration [NA]

View source ↗

Summary

This document updates the status of a long-term follow-up clinical trial of Hearticellgram-AMI for acute myocardial infarction, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Hearticellgram-AMI

Snippet

Sponsor: Pharmicell Co., Ltd. | Conditions: Acute Myocardial Infarction | NA | Status: RECRUITING